L-carnitine
Dietary SupplementOther names: L-carnitine-L-tartrate
NCT Number: NCT05009654
The primary aim of the current research project is to explore whether leucine stimulates carnitine transport, and thus affecting muscle carnitine content.
A secondary aim of this project is to investigate the effect of carnitine with leucine supplementation on muscle strength and body composition.
Looking for future studies?
Notify Me18 year–29 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: L-carnitine-L-tartrate
Time frame: 24 weeks
vastus lateralis muscle biopsy taken before and after the supplementation procedure (~20 cm proximal to the knee joint using a thin biopsy needle); carnitine concentration determined using ultra performance liquid chromatography - tandem mass spectrometer (UPLC-MS/MS) method
Time frame: 24 weeks
Peak torque measured by performing maximum voluntary contractions during isometric knee extension and flexion. The test performed in concentric-concentric mode consisting maximum 4-s knee extensor isometric contraction and maximum 4-s knee flexor isometric contraction, separated by 20-s recovery, repeated three times. Muscle isokinetic strength assessed in 5 repetitions of flexion and extension at a speed of 60°/s. Muscle endurance assessed in 10 repetitions at 300°/s determine the ability of the muscle to maintain the work. Strength testing performed on the Biodex System 4 Pro dynamometer.
Time frame: 24 weeks
The InBody720 measures impedance of five segments of the body (each arm, each leg, trunk) at frequencies of 1, 5, 50, 250, 500, and 1000 kHz through the 8-polar tactile-electrode. Based on the impedance, body fat mass, fat free mass, and skeletal muscle mass are calculated.
Gdansk University of Physical Education and Sport
Other
Carnitine Supplementation and Skeletal Muscle Function in Aging
Acronym: ROL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05296096
Atrophy, Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT06458530
Atrophy, Diabetes Mellitus
Durham, North Carolina, United States
View Trial DetailsNCT05927623
Aging, Atrophy
Calgary, Alberta, Canada
View Trial DetailsNCT06497426
Atrophy, Muscle Loss
Mataró, Barcelona, Spain
View Trial Details